Clinical significance of cytotoxin-associated gene A status of Helicobacter pylori among non-steroidal anti-inflammatory drug users with peptic ulcer bleeding: A multicenter case-control study

Scandinavian Journal of Gastroenterology

Volumn 39, Issue 12, 2004, Pages 1180-1185

  Tzourmakliotis, Dimitrios ^a   Economou, M ^a   Manolakopoulos, S ^a   Bethanis, S ^a   Bergele, C ^a   Lakoumentas, J ^a   Sclavos, P ^a   Milionis, H ^a   Margeli, A ^a   Vogiatzakis, E ^a   Avgerinos, A ^a  

^a NONE

Author keywords

Bleeding; CagA; H. pylori; NSAIDs; Peptic ulcer

Indexed keywords

CAGA PROTEIN; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; AGED; ARTICLE; BACTERIAL INFECTION; BACTERIAL STRAIN; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG USE; DYSPEPSIA; ENDOSCOPY; ESOPHAGUS BIOPSY; FEMALE; HELICOBACTER PYLORI; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NONHUMAN; PEPTIC ULCER; PEPTIC ULCER BLEEDING; PRIORITY JOURNAL; RISK FACTOR; SIDE EFFECT; SMOKING;

ADULT; AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; CASE-CONTROL STUDIES; DUODENAL ULCER; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; PEPTIC ULCER HEMORRHAGE; RISK FACTORS; STOMACH ULCER;

EID: 10644224176     PISSN: 00365521     EISSN: None     Source Type: Journal    
DOI: 10.1080/00365520410008123     Document Type: Article

References (44)

1. Schubert TT, Bologna SD, Nensey Y, Schubert A, Mascha E, Chan K. Ulcer risk factors: interactions between Helicobacter pylori infection, nonsteroidal use and age. Am J Med 1993;94: 413-8.
2. Langman MJS, Weil J, Wainwright P, Lawson DH, Rawlins MD, Logan RFA, et al. Risks of bleeding peptic ulcer associated with individual non-steroidal anti-inflammatory drugs. Lancet 1994; 343:1075-8.
3. Aalykke C, Lauritsen JM, Hallas J, Reinholdt S, Krogfelt K, Lauritsen K. Helicobacter pylori and risk of ulcer bleeding among users of nonsteroidal anti-inflammatory drugs: a case-control study. Gastroenterology 1999;116:1305-9.
4. Weil J, Langman MJS, Wainwright P, Lawson DH, Rawlins MD, Logan RFA, et al. Peptic ulcer bleeding: accessory risk factors and interactions with non-steroidal anti-inflammatory drugs. Gut 2000;46:27-31.
5. Kuyvenhoven JPh, Veenendaal RA, Vandenbroucke JP. Peptic ulcer bleeding: interaction between non-steroidal anti-Inflammatory drugs, Helicobacter pylori infection, and the ABO blood group system. Scand J Gastroenterol 1999;34:1082-6.
6. Santolaria S, Lanas A, Benito R, Pẽrez-Aisa MA, Montoro M, Sainz R. Helicobacter pylori infection is a protective factor for bleeding gastric ulcers but not for bleeding duodenal ulcers in NSAID users. Aliment Pharmacol Ther 1999;13:1511-8.
7. Cullen DJE, Hawkey GM, Greenwood DC, Humphreys H, Shepherd V, Logan RFA, et al. Peptic ulcer bleeding in the elderly: relative roles of Helicobacter pylori and non-steroidal anti-inflammatory drugs. Gut 1997;41:459-62.
8. Pilotto A, Leandro G, Di Mario F, Franceschi M, Bozzola L, Valerio G. Role of Helicobacter pylori infection on upper gastrointestinal bleeding in the elderly. A case-control study. Dig Dis Sci 1997;42:586-91.
9. Ng TM, Fock KM, Khor JL, Teo EK, Sim CS, Tan AL, et al. Non-steroidal anti-inflammatory drugs, Helicobacter pylori and bleeding gastric ulcer. Aliment Pharmacol Ther 2000;14:203-9.
10. Bianchi Porro G, Parente F, Imbesi V, Montrone F, Caruso I. Role of Helicobacter pylori in ulcer healing and recurrence of gastric and duodenal ulcers in long-term NSAID users: response to omeprazole dual therapy. Gut 1996;39:22-6.
11. Chan FKL, Sung JJY, Chung SCS, To KF, Yung MY, Leung VKS, et al. Randomised trial of eradication of Helicobacter pylori before non-steroidal anti-inflammatory drug therapy to prevent peptic ulcers. Lancet 1997;350:975-9.
12. Chan FKL, Sung JJY, Suen R, Lee YT, Wu JCY, Leung WK, et al. Does eradication of Helicobacter pylori impair healing of nonsteroidal anti-inflammatory drug associated bleeding peptic ulcers? A prospective randomized study. Aliment Pharmacol Ther 1998;12:1201-5.
13. Hawkey CJ, Tulassay Z, Szczepanski L, van Rensburg CJ, Fillipowicz-Sosnowska A, Lanas A, et al. Randomised controlled trial of Helicobacter pylori eradication in patients on nonsteroidal anti-inflammatory drugs: HELP NSAIDs study. Lancet 1998;352:1016-21.
14. Chan FKL, To KF, Wu JCY, Yung MY, Leung WK, Kwok T, et al. Eradication of Helicobacter pylori and risk of peptic ulcers in patients starting long-term treatment with non-steroidal anti-inflammatory drugs: a randomised trial. Lancet 2002;5:9-13.
15. Lai KC, Lam SK, Chu KM, Wong BCY, Hui WM, Wayne HC, et al, Lansoprazole for the prevention of recurrences of ulcer complications from long-term low-dose aspirin use. N Engl J Med 2002;346:2033-8.
16. Blaser MJ. Not all Helicobacter pylori strains are created equal: should all be eliminated? Lancet 1997;349:1020-2.
17. Weel JF, Van der Hulst RW, Gerrits Y, Roorda P, Feller M, Danken TGN, et al. The interrelation between cytotoxin-associated gene A, vacuolating cytotoxin and Helicobacter pylori-related diseases. J Infect Dis 1996;173:1171-5.
18. Van Doom LJ, Figueiredo C, Sanna R, Plaisier A, Schneeberger P, De Boer W, et al. Clinical relevance of the CagA, vacA, and iceA status of Helicobacter pylori. Gastroenterology 1998;115: 58-66.
19. Holvoet J, Terriere L, Van Hee W, Verbist L, Fierens E, Hautekeete ML. Relation of upper gastrointestinal bleeding to non-steroidal anti-inflammatory drugs and aspirin: a case control study. Gut 1991;32:730-4.
20. Katschinski B, Logan R, Davies J, Faulkner G, Pearson J, Langman M. Prognostic factors in upper gastrointestinal bleeding. Dig Dis Sci 1994;39:706-12.
21. Rodriguez GLA, Jick H. Risk of upper gastrointestinal bleeding and perforation associated with individual non-steroidal anti-inflammatory drugs. Lancet 1994;343 (8900):769-72.
22. Rothman KJ. Modern epidemiology. Boston: Little Brown; 1986. p. 237-83311-26.
23. Talley NJ, Stanghellini V, Heading RC, Koch KL, Malagelada JR, Tytgat GNJ. Functional gastroduodenal disorders. Gut 1999; 45 Suppl II:II37-42.
24. Cutler AF, Havstad S, Ma CK, Blaser MJ, Perez-Perez GI, Schubert TT. Accuracy of invasive and noninvasive tests to diagnose Helicobacter pylori infection. Gastroenterology 1995; 109:136-41.
25. Antoine C, Lozniewski A, De Korwin JD, Conroy MC, Feldman L, Duprez A, et al. Comparative study of four commercialized serological methods for the diagnosis of gastric Helicobacter pylori infection. Gastroenterol Clin Biol 1995;19:182-8.
26. Ching CK, Wong BC, Kwok E, Ong L, Covacci A, Lam SK. Prevalence of CagA-bearing Helicobacter pylori strains detected by the anti-CagA assay in patients with peptic ulcer disease and in controls. Am J Gastroenterol 1996;91:949-53.
27. Wu CY, Poon SK, Chen GH, Chang CS, Yeh HZ. Interaction between Helicobacter pylori and non-steroidal anti-inflammatory drugs in peptic ulcer bleeding. Scand J Gastroenterol 1999; 34:234-7.
28. Labenz J, Peitz U, Kohl H, Kaiser L, Malfertheiner P, Hackelsberger A, et al. Helicobacter pylori increases the risk of peptic ulcer bleeding: a case-control study. Ital J Gastroenterol Hepatol 1999;31:110-5.
29. Stack WA, Atherton JC, Hawkey GM, Logan RF, Hawkey CJ. Interactions between Helicobacter pylori and other risk factors for peptic ulcer bleeding. Aliment Pharmacol Ther 2002; 16:497-506.
30. Huang JQ, Sridhar S, Hunt RH. Role of Helicobacter pylori infection and non-steroidal anti-inflammatory drugs in peptic-ulcer disease: a meta-analysis. Lancet 2002;359:14-22.
31. Bombardier C, Laine L, Reicin A, Shapiro D, Burgos-Vargas R, Davis B, et al. VIGOR Study Group. Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. N Engl J Med 2000;343:1520-8.
32. Rokkas T, Liatsos C, Karameris A, Petridou E, Papatheodorou G, Kalafatis MD. Serologic detection of CagA positive Helicobacter pylori strains predicts the presence of peptic ulcer in young dyspeptic patients. Gastrointest Endosc 1999;50:511-5.
33. Crabtree JE, Taylor JD, Wyatt JI, Heatley RV, Shallcross TM, Tompkins DS, et al. Mucosal IgA recognition of Helicobacter pylori 120 kDa protein peptic ulceration, and gastric pathology. Lancet 1991;338 (8763):332-5.
34. Lanas A, Fuentes J, Benito R, Serrano P, Bajador E, Sainz R. Helicobacter pylori increases the risk of upper gastrointestinal bleeding in patients taking low-dose aspirin. Aliment Pharmacol Ther 2002;16:779-86.
35. Archimandritis A, Bitsikas J, Tjivras M, Fertakis A, Anastasakou E, Pitsouni E, et al. Helicobacter pylori infection in Greece in healthy people and in patients with peptic ulcer and with dyspepsia without ulcer. J Clin Gastroenterol 1993; 16:257-8.
36. Somerville K, Faulkner G, Langman M. Non-steroidal anti-inflammatory drugs and bleeding peptic ulcer. Lancet 1986;1 (8479):462-4.
37. Henry D, Lim LL-Y, Garcia Rodriguez GLA, Gutthan SP, Carson JL, Griffin M, et al. Variability in risk of gastrointestinal complications with individual non-steroidal anti-inflammatory drugs: results of a collaborative meta-analysis. Br Med J 1996; 312:1563-6.
38. Laine L. Approaches to nonsteroidal anti-inflammatory drug use in the high-risk patient. Gastroenterology 2001;120:594-606.
39. Leung WK, Sung JJY, Siu KLK, Chan FKL, Ling TKW, Cheng AFB. False-negative biopsy urease test in bleeding ulcers caused by the buffering effects of blood. Am J Gastroenterol 1998;93: 1914-8.
40. Wang WM, Chen CY, Jan CM, Chen LT, Perng DS, Lin SR, et al. Long-term follow-up and serological study after triple therapy of Helicobacter pylori-associated duodenal ulcer. Am J Gastroenterol 1994;89:1793-6.
41. Atherton JC. Non-endoscopic tests in the diagnosis of Helicobacter pylori infection. Aliment Pharmacol Ther 1997;11 Suppl 1:11-20.
42. Hansen JM, Hallas J, Lauritsen JM, Bytzer P. Non-steroidal anti-inflammatory drugs and complications: a risk factor analysis for clinical decision-making. Scand J Gastroenterol 1996;31:126-30.
43. Talley NJ, Evans JM, Fleming KC, Harmsen WS, Zismeister AR, Melton LJ. Nonsteroidal anti-inflammatory drugs and dyspepsia in the elderly. Dig Dis Sci 1995;40:1345-50.
44. Talley NJ, Silverstein MD, Agreus L, Sonnenberg A, Holtmann G, et al. AGA technical review: evaluation of dyspepsia. Gastroenterology 1998;114:582-95.